Skip to main content

Table 1 The prognostic value of MSI/LOH status of loci in tumor-related genes and B5

From: Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity within tumor-related genes in colorectal cancer

Loci

Total (n = 256)

II (n = 127)

III (n = 93)

Chemotherapy (n = 132)

OS

PFS

OS

PFS

OS

PFS

OS

PFS

D17S250

MSI p = 0.001

MSI p = 0.02

MSI p = 0.006

–

MSI p = 0.002

MSI p = 0.01

MSI p = 0.023

–

MSH2-15

MSI p = 0.001

MSI p = 0.006

MSI p = 0.001

MSI p = 0.001

–

–

–

–

pinch-5

MSI p = 0.03

–

MSI p = 0.001

MSI p = 0.001

–

–

–

–

MCC-25

–

MSI p = 0.048

MSI p = 0.024

MSI p = 0.01

–

–

–

–

MCC-10

MSI p = 0.001

MSI p = 0.001

MSI p = 0.001

MSI p = 0.001

MSI p = 0.003

MSI p = 0.001

MSI p = 0.001

MSI p = 0.001

MCC-3

–

–

MSI p = 0.036

–

–

–

–

–

MCC-26

–

–

MSI p = 0.049

–

–

–

–

–

MGMT-10

–

–

MSI p = 0.04

MSI p = 0.02

–

–

–

–

APC-6

–

–

MSI p = 0.049

–

–

–

–

–

BRAF-9

–

–

–

MSI p = 0.019

–

LOH p = 0.001

–

–

P21

–

–

–

–

LOH p = 0.009

LOH p = 0.021

–

–

MLH1-2

–

–

–

–

LOH p = 0.006

LOH p = 0.004

–

–

Pinch-13

–

–

–

–

–

LOH p = 0.035

–

–

BAT25

–

–

–

–

–

–

LOH p = 0.048

–

  1. Total, all of the patients; II, stage II patients; III, stage III patients; Chemotherapy, patients received adjuvant chemotherapy; OS, 5-year overall survival; PFS, 5-year progression free survival. MSI, MSI status of the loci is related to OS or PFS; LOH, LOH status of the loci is related to OS or PFS. p values were obtained from log-rank test